Protocol No.: ORION-20

CKJX839C12303 - Two part (double-blind inclisiran versus placebo [Year 1] followed by open-label inclisiran [Year 2]) randomized multicenter study to evaluate safety, tolerability and efficacy of inclisiran in children (6 to less than 12 years) with heterozygous familial hypercholesterolemia and elevated LDL-cholesterol (ORION-20)
Principal Investigator
Pyles, Lee
Phase
III
Age Group
Children
Applicable Disease Site
Other
Participating Institutions
Health Sciences Center
West Virginia University
Contacts
Nathaniel King, RN
Clinical Nurse Coordinator
Phone: +1 304-293-9512
Nathaniel King, RN
Clinical Nurse Coordinator
Phone: +1 304-293-9512

View on ClinicalTrials.gov